| Fonds | 2026/Q1 | 2025/Q4 | 2025/Q3 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | |
| 919.972.163 $ | -68.576.746 $ | +20,7 % | 1.197.359.192 $ | -117.441.034 $ | -2,3 % | 1.226.925.416 $ | |||
| Bain Capital Life Sciences Investors, LLC | 254.203.684 $ | -108.660.122 $ | -29,9 % | 362.863.806 $ | -56.141.192 $ | -13,4 % | 419.004.998 $ | ||
| WELLINGTON MANAGEMENT GROUP LLP | 291.528.944 $ | +119.716.804 $ | +69,7 % | 171.812.140 $ | +7.549.185 $ | +4,6 % | 164.262.955 $ | ||
| HealthCor Partners Management LP | 50.655.401 $ | -144.578.356 $ | -74,1 % | 195.233.757 $ | -30.205.979 $ | -13,4 % | 225.439.736 $ | ||
| FMR LLC | 131.328.537 $ | +11.147.354 $ | +9,3 % | 120.181.183 $ | -39.038.496 $ | -24,5 % | 159.219.679 $ | ||
| BAILLIE GIFFORD & CO | 87.624.842 $ | -13.557.050 $ | -13,4 % | 101.181.892 $ | |||||
| BAMCO INC /NY/ | 93.123.829 $ | +25.965.814 $ | +38,7 % | 67.158.015 $ | +25.503.563 $ | +61,2 % | |||
| Schusterman Interests, LLC | 56.527.709 $ | -8.745.797 $ | -13,4 % | 65.273.506 $ | |||||
| Janus Henderson Group Ltd. | 53.063.035 $ | +27.831.760 $ | +110,3 % | ||||||
| VANGUARD GROUP INC | 46.066.124 $ | -2.805.268 $ | -5,7 % | 48.871.392 $ | |||||
| Capricorn Investment Group LLC | 48.177.645 $ | ||||||||
| VANGUARD CAPITAL MANAGEMENT LLC | 46.068.733 $ | ||||||||
| Capital International Investors | 43.671.258 $ | ||||||||
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 41.713.971 $ | ||||||||
| 919.972.163 $ | -68.576.746 $ | +20,7 % | 1.197.359.192 $ | -117.441.034 $ | -2,3 % | 1.226.925.416 $ | |||